Skip to main content

Table 1 Baseline characteristics

From: The effect of exenatide on fasting bile acids in newly diagnosed type 2 diabetes mellitus patients, a pilot study

Parameters

T2DM patients

Healthy subjects

P-valuea

(n = 38)

(n = 38)

Age, years

48.2 ± 9.0

52.9 ± 15.7

0.074

Male, %

17, 44.7%

18, 47.4%

 

Height, cm

170.7 ± 9.4

171.7 ± 6.02

0.572

Weight, kg

93.1 ± 17.1

90.1 ± 8.3

0.722

BMI, kg/m2

31.2 (28.5, 35.1)

30.8 (27.7, 33.9)

0.684

TC, mmol/L

5.05 ± 1.11

4.09 ± 0.77

<0.01

HDL-C, mmol/L

1.15 ± 0.46

1.14 ± 0.30

0.995

LDL-C, mmol/L

2.92 ± 0.80

2.23 ± 0.54

<0.01

TG, mmol/L

2.16 (1.26, 4.21)

1.30 (0.87, 2.07)

<0.01

FPG, mmol/L

9.19 ± 3.46

4.41 ± 0.95

<0.01

FTBAs, μmol/L

3.84 ± 2.06

3.87 ± 2.89

0.954

  1. Data presented as means ± SD or medians (interquartile range)
  2. P value was calculated by independent sample T test
  3. aT2DM patients vs. healthy subjects